Marvin Moser

NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY.

Comprehensive NeuroScience (CNS) is a strategic clinical research partner providing a full range of services in various therapeutic areas with an outstanding record for consistently delivering quality and success on time and within budget. CNS continues to dominate the therapeutic development process by standing as a strategic partner poised with expertise in central nervous system disorders and multiple therapeutic areas, research methodologies, regulatory requisites and evolving patient needs. CNS is dedicated to open and effective communication at all organizational levels, and to supporting sponsor confidence through simplified contracting, timely enrollment, proactive trial execution, and quality data delivery. CNS delivers accelerated product development that is coupled with integrated clinical trial management services and high quality investigative site research services for all phases within three separate divisions.